Biomarker Testing and Patterns of Treatment in Patients with NSCLC: An International Association for The Study of Lung Cancer Analysis of American Society of Clinical Oncology CancerLinQ Discovery Data
In this analysis of a United States-based real-world data set of patients with stage IV NSCLC, the Asian race and female sex were associated with a higher likelihood of having biomarker testing performed. The overall percentage of patients undergoing testing remained suboptimal.
Authors
- Madhusmita Behera (ORCID: https://orcid.org/0000-0003-1121-6002)
- Chandra P. Belani (ORCID: https://orcid.org/0000-0001-5049-5329)
- Jeffrey M. Switchenko (ORCID: https://orcid.org/0000-0002-5563-9325)
- Murry W. Wynes
- Zhonglu Huang
- Ming‐Sound Tsao (ORCID: https://orcid.org/0000-0002-9160-5405)
- Lecia V. Sequist (ORCID: https://orcid.org/0000-0002-8965-6991)
- Giorgio V. Scagliotti (ORCID: https://orcid.org/0000-0001-6646-958X)
- Gregory J. Joseph
- Suresh S. Ramalingam (ORCID: https://orcid.org/0000-0002-0757-3106)
- Manali Rupji
- Becky Bunn
Institutions
- University Health Network (CA)
- Harvard University (US)
- Emory University (US)
- Princess Margaret Cancer Centre (CA)
- International Association for the Study of Lung Cancer (US)
- University of Turin (IT)
- Penn State Milton S. Hershey Medical Center (US)
Publication Details
- Journal
- JTO Clinical and Research Reports
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1016/j.jtocrr.2025.100816
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00